{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:15:00Z","timestamp":1788268500075,"version":"build-2803163510"},"reference-count":39,"publisher":"American Veterinary Medical Association (AVMA)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ajvr"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"sc_a1\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the short-term effect of sedation on GFR markers in cats with chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a2\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective observational study involving client-owned cats with CKD undergoing abdominal sonography. Each cat received 50 mg oral gabapentin, 0.3 mg\/kg butorphanol, and 0.3 mg\/kg midazolam IM followed by 1 mg\/kg alfaxalone IV to effect. Presedation blood tests included hematology and biochemistry. A second blood test for GFR markers (symmetric dimethylarginine [SDMA] and creatinine) was collected at the point of maximum sedation (20 cats) or 2 hours after sedation (12 cats).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a3\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      20 cats had presedation SDMA and creatinine concentrations of 19 \u00b5g\/dL median (IQR, 15 to 24.5) and 200 \u00b5mol\/L median (IQR, 147.5 to 260), respectively. These were not significantly different from samples from the point of maximal sedation (SDMA: median, 19 \u00b5g\/dL; quantile [Q]-1 to Q3, 15 to 24.5;\n                      <jats:italic>P<\/jats:italic>\n                      = .31; creatinine: median, 200 \u00b5mol\/L; IQR, 147.5 to 255;\n                      <jats:italic>P<\/jats:italic>\n                      = .71). Twelve cats had presedation SDMA and creatinine concentrations of 22 \u00b5g\/dL median (IQR, 19.5 to 24.5) and 210 \u00b5mol\/L median (IQR, 165 to 260), respectively. These were not significantly different from samples obtained 2 hours after sedation (SDMA: median, 25 \u00b5g\/dL; IQR, 20 to 26;\n                      <jats:italic>P<\/jats:italic>\n                      = .51; creatinine: median, 200 \u00b5mol\/L; Q1 to Q3, 175 to 280;\n                      <jats:italic>P<\/jats:italic>\n                      = .06). The only adverse effect was prolonged sedation in some cats.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a4\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sedation with gabapentin, butorphanol, midazolam, and alfaxalone was an effective protocol for cats with CKD undergoing noninvasive diagnostic procedures and was not associated with short-term changes in GFR markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sc_a5\">\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>The sedation protocol described is safe and effective in cats with CKD undergoing routine procedures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/ajvr.26.03.0088","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:56:23Z","timestamp":1779998183000},"source":"Crossref","is-referenced-by-count":0,"title":["Short-term effect of sedation on kidney function markers in cats with chronic kidney disease"],"prefix":"10.2460","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9862-1723","authenticated-orcid":true,"given":"Zhan Hong","family":"Chew","sequence":"first","affiliation":[{"name":"Small Animal Specialist Hospital, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna D.","family":"White","sequence":"additional","affiliation":[{"name":"Small Animal Specialist Hospital, North Ryde, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"2","key":"B1","series-title":"Vet J","first-page":"286","article-title":"Prevalence of disorders recorded in cats attending primary-care veterinary practices in England","volume":"202","author":"O\u2019Neill DG","year":"2014","unstructured":"O\u2019Neill DG, Church DB, McGreevy PD, Thomsom PC, Brodbelt DC. Prevalence of disorders recorded in cats attending primary-care veterinary practices in England. Vet J. 2014;202(2):286\u2013291. doi:10.1016\/j.tvjl.2014.08.004"},{"issue":"2","key":"B2","series-title":"J Feline Med Surg","first-page":"1098612X231155016","article-title":"Commonly diagnosed disorders in domestic cats in the UK and their associations with sex and age","volume":"25","author":"O\u2019Neill DG","year":"2023","unstructured":"O\u2019Neill DG, Gunn-Moore D, Sorrell S, et al. Commonly diagnosed disorders in domestic cats in the UK and their associations with sex and age. J Feline Med Surg. 2023;25(2):1098612X231155016. doi:10.1177\/1098612X231155016"},{"issue":"6","key":"B3","series-title":"J Feline Med Surg","first-page":"465","article-title":"Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies","volume":"16","author":"Marino CL","year":"2014","unstructured":"Marino CL, Lascelles BDX, Vaden SL, Gruen ME, Marks SL. Prevalence and classification of chronic kidney disease in cats randomly selected from four age groups and in cats recruited for degenerative joint disease studies. J Feline Med Surg. 2014;16(6):465\u2013472. doi:10.1177\/1098612X13511446"},{"issue":"3","key":"B4","series-title":"J Feline Med Surg","first-page":"219","article-title":"ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease","volume":"18","author":"Sparkes AH","year":"2016","unstructured":"Sparkes AH, Caney S, Chalhoub S, et al. ISFM consensus guidelines on the diagnosis and management of feline chronic kidney disease. J Feline Med Surg. 2016;18(3):219\u2013239. doi:10.1177\/1098612X16631234"},{"key":"B5","series-title":"Ettinger\u2019s Textbook of Veterinary Internal Medicine","first-page":"2057","article-title":"Clinical approach and laboratory evaluation of renal disease","author":"Syme HM","year":"2024","unstructured":"Syme HM, Jepson R. Clinical approach and laboratory evaluation of renal disease. In: Ettinger SJ, Feldman EC, Cote E, eds. Ettinger\u2019s Textbook of Veterinary Internal Medicine. 9th ed. Elsevier Health Sciences; 2024:2057\u20132073."},{"issue":"7","key":"B6","series-title":"J Feline Med Surg","first-page":"602","article-title":"AAFP feline anesthesia guidelines","volume":"20","author":"Robertson SA","year":"2018","unstructured":"Robertson SA, Gogolski SM, Pascoe P, Shafford HL, Sager J, Griffenhagen GM. AAFP feline anesthesia guidelines. J Feline Med Surg. 2018;20(7):602\u2013634. doi:10.1177\/1098612X18781391"},{"issue":"1","key":"B7","series-title":"JFMS Open Rep","first-page":"2055116915585021","article-title":"Probable vasovagal reaction following cystocentesis in two cats","volume":"1","author":"Odunayo A","year":"2015","unstructured":"Odunayo A, Ng ZY, Holford AL. Probable vasovagal reaction following cystocentesis in two cats. JFMS Open Rep. 2015;1(1):2055116915585021. doi:10.1177\/2055116915585021"},{"issue":"11","key":"B8","series-title":"J Feline Med Surg","first-page":"1093","article-title":"2022 AAFP\/ISFM cat friendly veterinary interaction guidelines: approach and handling techniques","volume":"24","author":"Rodan I","year":"2022","unstructured":"Rodan I, Dowgray N, Carney HC, et al. 2022 AAFP\/ISFM cat friendly veterinary interaction guidelines: approach and handling techniques. J Feline Med Surg. 2022;24(11):1093\u20131132. doi:10.1177\/1098612X221128760"},{"issue":"6","key":"B9","series-title":"J Feline Med Surg","first-page":"535","article-title":"Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial","volume":"20","author":"Pankratz KE","year":"2018","unstructured":"Pankratz KE, Ferris KK, Griffith EH, Sherman BL. Use of single-dose oral gabapentin to attenuate fear responses in cage-trap confined community cats: a double-blind, placebo-controlled field trial. J Feline Med Surg. 2018;20(6):535\u2013543. doi:10.1177\/1098612X17719399"},{"issue":"10","key":"B10","series-title":"J Am Vet Med Assoc","first-page":"1175","article-title":"Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination","volume":"251","author":"van Haaften KA","year":"2017","unstructured":"van Haaften KA, Forsythe LRE, Stelow EA, Bain MJ. Effects of a single preappointment dose of gabapentin on signs of stress in cats during transportation and veterinary examination. J Am Vet Med Assoc. 2017;251(10):1175\u20131181. doi:10.2460\/javma.251.10.1175"},{"issue":"12","key":"B11","series-title":"J Feline Med Surg","first-page":"1260","article-title":"Serum concentrations of gabapentin in cats with chronic kidney disease","volume":"24","author":"Quimby JM","year":"2022","unstructured":"Quimby JM, Lorbach SK, Saffire A, et al. Serum concentrations of gabapentin in cats with chronic kidney disease. J Feline Med Surg. 2022;24(12):1260\u20131266. doi:10.1177\/1098612X221077017"},{"key":"B12","series-title":"Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones","year":"2015","unstructured":"Grimm KA, Lamont LA, Tranquilli WJ, Greene SA, Robertson SA, eds. Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones. Wiley-Blackwell; 2015."},{"issue":"9","key":"B13","series-title":"Am J Vet Res","first-page":"1222","article-title":"Effect of sedation protocol on glomerular filtration rate in cats as determined by use of quantitative renal scintigraphy","volume":"72","author":"Winter MD","year":"2011","unstructured":"Winter MD, Miles K, Riedesel DH. Effect of sedation protocol on glomerular filtration rate in cats as determined by use of quantitative renal scintigraphy. Am J Vet Res. 2011;72(9):1222\u20131225. doi:10.2460\/ajvr.72.9.1222"},{"issue":"2","key":"B14","series-title":"Vet J","first-page":"141","article-title":"A review of the pharmacology and clinical application of alfaxalone in cats","volume":"203","author":"Warne LN","year":"2015","unstructured":"Warne LN, Beths T, Whittem T, Carter JE, Bauquier SH. A review of the pharmacology and clinical application of alfaxalone in cats. Vet J. 2015;203(2):141\u2013148. doi:10.1016\/j.tvjl.2014.12.011"},{"issue":"5","key":"B15","series-title":"Vet Radiol Ultrasound","first-page":"458","article-title":"The effect of a combination of medetomidine-butorphanol and medetomidine, butorphanol, atropine on glomerular filtration rate in dogs","volume":"42","author":"Grimm JB","year":"2001","unstructured":"Grimm JB, Grimm KA, Kneller SK, et al. The effect of a combination of medetomidine-butorphanol and medetomidine, butorphanol, atropine on glomerular filtration rate in dogs. Vet Radiol Ultrasound. 2001;42(5):458\u2013462. doi:10.1111\/j.1740-8261.2001.tb00970.x"},{"issue":"2","key":"B16","series-title":"J Am Anim Hosp Assoc","first-page":"70","article-title":"Effects of intramuscular alfaxalone\/acepromazine on echocardiographic, biochemical, and blood gas measurements in healthy cats","volume":"55","author":"Kim B","year":"2019","unstructured":"Kim B, Jang M, Sohn J, et al. Effects of intramuscular alfaxalone\/acepromazine on echocardiographic, biochemical, and blood gas measurements in healthy cats. J Am Anim Hosp Assoc. 2019;55(2):70\u201377. doi:10.5326\/JAAHA-MS-6630"},{"issue":"2","key":"B17","series-title":"J Feline Med Surg","first-page":"95","article-title":"Comparison of two intramuscular sedation protocols on sedation, recovery and ease of venipuncture for cats undergoing blood donation","volume":"21","author":"Reader RC","year":"2019","unstructured":"Reader RC, Barton BA, Abelson AL. Comparison of two intramuscular sedation protocols on sedation, recovery and ease of venipuncture for cats undergoing blood donation. J Feline Med Surg. 2019;21(2):95\u2013102. doi:10.1177\/1098612X18760434"},{"issue":"8","key":"B18","series-title":"J Feline Med Surg","first-page":"793","article-title":"Evaluation of an intramuscular butorphanol and alfaxalone protocol for feline blood donation: a pilot study","volume":"20","author":"Granfone MC","year":"2018","unstructured":"Granfone MC, Walker JM, Smith LJ. Evaluation of an intramuscular butorphanol and alfaxalone protocol for feline blood donation: a pilot study. J Feline Med Surg. 2018;20(8):793\u2013798. doi:10.1177\/1098612X17732484"},{"issue":"5","key":"B19","series-title":"Vet Anaesth Analg","first-page":"417","article-title":"Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes","volume":"37","author":"Santos LC","year":"2010","unstructured":"Santos LC, Ludders JW, Erb HN, Basher KL, Kirch P, Gleed RD. Sedative and cardiorespiratory effects of dexmedetomidine and buprenorphine administered to cats via oral transmucosal or intramuscular routes. Vet Anaesth Analg. 2010;37(5):417\u2013424. doi:10.1111\/j.1467-2995.2010.00555.x"},{"issue":"9","key":"B20","series-title":"J Feline Med Surg","first-page":"736","article-title":"Measurement of glomerular filtration rate in cats: methods and advantages over routine markers of renal function","volume":"16","author":"Finch N","year":"2014","unstructured":"Finch N. Measurement of glomerular filtration rate in cats: methods and advantages over routine markers of renal function. J Feline Med Surg. 2014;16(9):736\u2013748. doi:10.1177\/1098612X14545274"},{"issue":"6","key":"B21","series-title":"J Vet Intern Med","first-page":"1676","article-title":"Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease","volume":"28","author":"Hall JA","year":"2014","unstructured":"Hall JA, Yerramilli M, Obare E, Yerramilli M, Jewell DE. Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014;28(6):1676\u20131683. doi:10.1111\/jvim.12445"},{"issue":"1","key":"B22","series-title":"J Vet Intern Med","first-page":"303","article-title":"Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function","volume":"35","author":"Brans M","year":"2021","unstructured":"Brans M, Daminet S, Mortier F, Duchateau L, Lefebvre HP, Paepe D. Plasma symmetric dimethylarginine and creatinine concentrations and glomerular filtration rate in cats with normal and decreased renal function. J Vet Intern Med. 2021;35(1):303\u2013311. doi:10.1111\/jvim.15975"},{"issue":"3","key":"B23","series-title":"J Vet Intern Med","first-page":"799","article-title":"Plasma symmetric dimethylarginine concentration in dogs with acute kidney injury and chronic kidney disease","volume":"31","author":"Dahlem DP","year":"2017","unstructured":"Dahlem DP, Neiger R, Schweighauser A, et al. Plasma symmetric dimethylarginine concentration in dogs with acute kidney injury and chronic kidney disease. J Vet Intern Med. 2017;31(3):799\u2013804. doi:10.1111\/jvim.14694"},{"issue":"5","key":"B24","series-title":"J Vet Intern Med","first-page":"1669","article-title":"Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease","volume":"36","author":"Loane SC","year":"2022","unstructured":"Loane SC, Thomson JM, Williams TL, McCallum KE. Evaluation of symmetric dimethylarginine in cats with acute kidney injury and chronic kidney disease. J Vet Intern Med. 2022;36(5):1669\u20131676. doi:10.1111\/jvim.16497"},{"issue":"3","key":"B25","series-title":"Anesthesiology","first-page":"488","article-title":"Modification of GABA-mediated inhibition by various injectable anesthetics","volume":"77","author":"Albertson TE","year":"1992","unstructured":"Albertson TE, Walby WF, Joy RM. Modification of GABA-mediated inhibition by various injectable anesthetics. Anesthesiology. 1992;77(3):488\u2013499. doi:10.1097\/00000542-199209000-00014"},{"issue":"2","key":"B26","series-title":"Brain Res","first-page":"287","article-title":"Modulation of the GABA receptor complex by a steroid anaesthetic","volume":"323","author":"Harrison NL","year":"1984","unstructured":"Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 1984;323(2):287\u2013292. doi:10.1016\/0006-8993(84)90299-3"},{"issue":"1","key":"B27","series-title":"Prog Neurobiol","first-page":"67","article-title":"Neurosteroid modulation of GABAA receptors","volume":"71","author":"Lambert JJ","year":"2003","unstructured":"Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABAA receptors. Prog Neurobiol. 2003;71(1):67\u201380. doi:10.1016\/j.pneurobio.2003.09.001"},{"issue":"8","key":"B28","series-title":"J Vet Med Sci","first-page":"897","article-title":"Sedative effects of intramuscular alfaxalone administered to cats","volume":"77","author":"Tamura J","year":"2015","unstructured":"Tamura J, Ishizuka T, Fukui S, et al. Sedative effects of intramuscular alfaxalone administered to cats. J Vet Med Sci. 2015;77(8):897\u2013904. doi:10.1292\/jvms.14-0200"},{"issue":"6","key":"B29","series-title":"J Vet Pharmacol Ther","first-page":"571","article-title":"The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of alfaxan at clinical and supraclinical doses","volume":"31","author":"Whittem T","year":"2008","unstructured":"Whittem T, Pasloske KS, Heit MC, Ranasinghe MG. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of alfaxan at clinical and supraclinical doses. J Vet Pharmacol Ther. 2008;31(6):571\u2013579. doi:10.1111\/j.1365-2885.2008.00998.x"},{"issue":"1","key":"B30","series-title":"J Vet Med Sci","first-page":"73","article-title":"Comparison of the anesthetic effects between 5 mg\/kg of alfaxalone and 10 mg\/kg of propofol administered intravenously in cats","volume":"83","author":"Tamura J","year":"2021","unstructured":"Tamura J, Oyama N, Fukui S, Yamashita K. Comparison of the anesthetic effects between 5 mg\/kg of alfaxalone and 10 mg\/kg of propofol administered intravenously in cats. J Vet Med Sci. 2021;83(1):73\u201377. doi:10.1292\/jvms.20-0407"},{"issue":"11","key":"B31","series-title":"J Feline Med Surg","first-page":"775","article-title":"Feline acute kidney injury: 1. Pathophysiology, etiology and etiology-specific management considerations","volume":"14","author":"Monaghan K","year":"2012","unstructured":"Monaghan K, Nolan B, Labato M. Feline acute kidney injury: 1. Pathophysiology, etiology and etiology-specific management considerations. J Feline Med Surg. 2012;14(11):775\u2013784. doi:10.1177\/1098612X12464458"},{"issue":"2","key":"B32","series-title":"J Vet Intern Med","first-page":"379","article-title":"Renal biomarkers in cats: a review of the current status in chronic kidney disease","volume":"36","author":"Kongtasai T","year":"2022","unstructured":"Kongtasai T, Paepe D, Meyer E, et al. Renal biomarkers in cats: a review of the current status in chronic kidney disease. J Vet Intern Med. 2022;36(2):379\u2013396. doi:10.1111\/jvim.16377"},{"issue":"6","key":"B33","series-title":"Vet Clin North Am Small Anim Pract","first-page":"961","article-title":"Kidney disease and the nexus of chronic kidney disease and acute kidney injury: the role of novel biomarkers as early and accurate diagnostics","volume":"46","author":"Yerramilli M","year":"2016","unstructured":"Yerramilli M, Farace G, Quinn J, Yerramilli M. Kidney disease and the nexus of chronic kidney disease and acute kidney injury: the role of novel biomarkers as early and accurate diagnostics. Vet Clin North Am Small Anim Pract. 2016;46(6):961\u2013993. doi:10.1016\/j.cvsm.2016.06.011"},{"issue":"6","key":"B34","series-title":"J Vet Emerg Crit Care","first-page":"733","article-title":"Prospective evaluation of novel biomarkers of acute kidney injury in dogs following cardiac surgery under cardiopulmonary bypass","volume":"32","author":"Starybrat D","year":"2022","unstructured":"Starybrat D, Jepson R, Bristow P, et al. Prospective evaluation of novel biomarkers of acute kidney injury in dogs following cardiac surgery under cardiopulmonary bypass. J Vet Emerg Crit Care. 2022;32(6):733\u2013742. doi:10.1111\/vec.13250"},{"key":"B35","series-title":"Top Companion Anim Med","first-page":"100586","article-title":"Evaluation of urinary clusterin and cystatin B as biomarkers for renal injury in dogs envenomated by the European adder (Vipera berus)","author":"Harjen HJ","year":"2022","unstructured":"Harjen HJ, Anfinsen KP, Hultman J, et al. Evaluation of urinary clusterin and cystatin B as biomarkers for renal injury in dogs envenomated by the European adder (Vipera berus). Top Companion Anim Med. 2022;46:100586. doi:10.1016\/j.tcam.2021.100586"},{"issue":"7","key":"B36","series-title":"PLoS One","first-page":"e0255310","article-title":"The impact of periodontal disease and dental cleaning procedures on serum and urine kidney biomarkers in dogs and cats","volume":"16","author":"Hall JA","year":"2021","unstructured":"Hall JA, Forman FJ, Bobe G, Farace G, Yerramilli M. The impact of periodontal disease and dental cleaning procedures on serum and urine kidney biomarkers in dogs and cats. PLoS One. 2021;16(7):e0255310. doi:10.1371\/journal.pone.0255310"},{"key":"B37","series-title":"Res Vet Sci","first-page":"12","article-title":"Urinary clusterin and cystatin B as biomarkers of tubular injury in dogs following envenomation by the European adder","author":"Gordin E","year":"2021","unstructured":"Gordin E, Gordin D, Viitanen S, et al. Urinary clusterin and cystatin B as biomarkers of tubular injury in dogs following envenomation by the European adder. Res Vet Sci. 2021;134:12\u201318. doi:10.1016\/j.rvsc.2020.11.019"},{"issue":"6","key":"B38","series-title":"J Vet Intern Med","first-page":"2251","article-title":"Urinary cystatin b differentiates progressive versus stable IRIS stage 1 chronic kidney disease in dogs","volume":"37","author":"Segev G","year":"2023","unstructured":"Segev G, Vaden S, Ross S, et al. Urinary cystatin b differentiates progressive versus stable IRIS stage 1 chronic kidney disease in dogs. J Vet Intern Med. 2023;37(6):2251\u20132260. doi:10.1111\/jvim.16887"},{"key":"B39","series-title":"Vet J","first-page":"106262","article-title":"Urinary Cystatin B as a marker of acute kidney injury in cats","author":"Chen H","year":"2024","unstructured":"Chen H, Avital Y, Peterson S, et al. Urinary Cystatin B as a marker of acute kidney injury in cats. Vet J. 2024;308:106262."}],"container-title":["American Journal of Veterinary Research"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/9\/ajvr.26.03.0088.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/9\/ajvr.26.03.0088.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/ajvr\/87\/9\/ajvr.26.03.0088.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:25:31Z","timestamp":1788265531000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/ajvr\/87\/9\/ajvr.26.03.0088.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":39,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.2460\/ajvr.26.03.0088","relation":{},"ISSN":["0002-9645","1943-5681"],"issn-type":[{"value":"0002-9645","type":"print"},{"value":"1943-5681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}